Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ENTG✓SelectedUSD · ENTGMRNA vs ENTG performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs ENTG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
ENTG return
+22.6%
Excess return
+124.4%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioENTGExcessAlpha
1D-2.2%-9.9%+7.7%+0.5%
7D-12.7%-15.5%+2.8%-8.7%
30D-20.7%-15.6%-5.0%-17.2%
3M+46.3%-13.8%+60.1%+50.9%
6M+305.2%-2.3%+307.6%+273.9%
YTD+561.2%+48.3%+513.0%+399.1%
1Y+772.1%+81.6%+690.5%+503.5%
3Y+147.0%+19.6%+127.4%+78.4%
All+147.0%+22.6%+124.4%+78.4%

Cumulative growth

Daily Returns

Daily percentage return beside ENTG.

Daily Out/Under-Performance

Portfolio return minus ENTG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ENTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ENTG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling